Close Menu

Technology Review has a Q&A with Ken Offit, chief of the clinical genetics service at Memorial Sloan-Kettering Cancer Center, who is leading a new study looking for protective variants in women with mutations in BRCA2. He hopes to use SNP arrays and a large number of study participants worldwide to find what factors might protect women who are genetically predisposed to getting breast cancer from getting it.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.